Search results
Insider Selling: CEO Matthew Oppenheimer Sells 20,832 Shares of Remitly Global Inc (RELY)
GuruFocus.com via Yahoo Finance· 14 hours agoOn May 14, 2024, Matthew Oppenheimer, the Chief Executive Officer of Remitly Global Inc...
Imax Touts 2025 Slate: Biggest-Ever Filmed With Its Cameras Includes ‘M:I 8’, ‘Superman: Legacy’ &...
Deadline via Yahoo News· 6 hours agoFollowing the global success of Oppenheimer and Dune: Part Two, Imax is looking forward to its...
Oppenheimer Cuts UroGen Pharma (NASDAQ:URGN) Price Target to $32.00
ETF DAILY NEWS· 17 hours agoUroGen Pharma (NASDAQ:URGN – Get Free Report) had its price objective lowered by Oppenheimer from $34.00 to $32.00 in a research report issued on Tuesday, Benzinga reports ...
PACS Group shares target raised by Oppenheimer on strong Q1 results By Investing.com
Investing.com· 1 day agoOn Wednesday, Oppenheimer increased the price target for PACS Group (NYSE: PACS) shares to $32 from...
Oppenheimer Expands Technology Investment Banking Group with Addition of Yogesh Amle
FOX 59 Indianapolis· 3 days agoOppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank and subsidiary of Oppenheimer...
Q2 2024 EPS Estimates for Sprouts Farmers Market, Inc. (NASDAQ:SFM) Raised by Analyst
ETF DAILY NEWS· 14 hours agoSprouts Farmers Market, Inc. (NASDAQ:SFM – Free Report) – Investment analysts at Zacks Research...
Imax Unveils 2025 Film Slate, Including ‘Superman’ and ‘The Fantastic Four’
The Hollywood Reporter via Yahoo News· 7 hours agoImax is going big for 2025, unveiling on Thursday that it will release at least 14 titles in its...
Why We’re All Living in Matthew Barney’s Sticky, Slimy World
New York Times· 1 day agoMax Hetzler in Paris. In his first New York solo show in 1991, a 23-year-old Barney presented a...
Amazon's Upfront Presentation Highlights Strong Push into Movies and Sports Advertising: Analyst -...
Benzinga· 1 day agoOppenheimer analyst Jason Helfstein reiterated an Outperform rating on Amazon.Com Inc AMZN with a...
Agilysys (NASDAQ:AGYS) Given New $100.00 Price Target at Oppenheimer
ETF DAILY NEWS· 17 hours agoAgilysys (NASDAQ:AGYS – Get Free Report) had its price objective lifted by research analysts at Oppenheimer from $95.00 to $100.00 in a note issued to investors on Tuesday ...